Showing results (81-90 of 752) with videos related to
Sort By:
Pageof 76
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 5, 2026
Current and emerging therapies in IDH-mutant gliomaVihang Nakhate, Gilbert Youssef, Patrick Y WenNeuro-Oncology|February 13, 2019
Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensusDavid Schiff, Martin Van den Bent, Michael A Vogelbaum, et al.Surgical Neurology|April 21, 2007
Adrenal insufficiency secondary to glucocorticoid withdrawal in patients with brain tumorArnaldo Neves Da Silva, David SchiffExpert Review of Neurotherapeutics|June 2, 2012
Angiogenic inhibition in high-grade gliomas: past, present and futureJasmin Jo, David Schiff, Benjamin PurowCurrent Treatment Options in Neurology|May 2, 2012
Spinal cord compressionEduardo Santamaria Carvalhal Ribas, David SchiffNeuro-Oncology|October 11, 2017
Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapyPatrick Y Wen, Jan Drappatz, John de Groot, et al.Journal of Neuro-Oncology|April 2, 2005
Paraneoplastic recurrent multifocal encephalitis presenting with epilepsia partialis continuaMelike Mut, David Schiff, Josep DalmauCurrent Oncology Reports|March 28, 2008
Reversible posterior leukoencephalopathy syndrome in cancerChristopher Vaughn, Louann Zhang, David SchiffArchives of Neurology|December 19, 2006
Clinical implications of status epilepticus in patients with neoplasmsRobert Cavaliere, Elana Farace, David SchiffNeuro-Oncology|October 17, 2017
Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapyTimothy F Cloughesy, Jan Drappatz, John de Groot, et al.Pageof 76